HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fraction
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: The Heart Failure Association (HFA)-PEFF score is recognized as a simple method to diagnose heart failure (HF) with preserved ejection fraction (HFpEF). This study aimed to evaluate the relationship between HFA-PEFF scores and cardiovascular outcomes in HFpEF patients. Methods: A total of 502 consecutive HFpEF patients were prospectively observed for up to 1,500 days. Cardiovascular outcomes were compared between two groups of patients, defined by their HFA-PEFF scores: those who scored 2–4 (the intermediate-score group) and those who scored 5–6 group (the high-score group). Overall, 236 cardiovascular events were observed during the follow-up period (median, 1,159 days). Results: Kaplan-Meier analysis showed that there were significant differences in composite cardiovascular events and HF-related events between the intermediate-score group and the high-score group (p = 0.003 and p < 0.001, respectively). Multivariate Cox proportional hazards analysis showed that the HFA-PEFF scores significantly predicted future HF-related events (hazard ratio, 1.66; 95% confidence interval [CI], 1.11 to 2.50; p = 0.014); receiver operating characteristic analysis confirmed this relationship (area under the curve, 0.633; 95% CI, 0.574 to 0.692; p < 0.001). The cutoff HFA-PEFF score for the identification of HF-related events was 4.5. Decision curve analysis revealed that combining the HFA-PEFF score with conventional prognostic factors improved the prediction of HF-related events. Conclusions: HFA-PEFF scores may be useful for predicting HF-related events in HFpEF patients.
Abstract
Background/Aims: The Heart Failure Association (HFA)-PEFF score is recognized as a simple method to diagnose heart failure (HF) with preserved ejection fraction (HFpEF). This study aimed to evaluate the relationship between HFA-PEFF scores and cardiovascular outcomes in HFpEF patients. Methods: A total of 502 consecutive HFpEF patients were prospectively observed for up to 1,500 days. Cardiovascular outcomes were compared between two groups of patients, defined by their HFA-PEFF scores: those who scored 2–4 (the intermediate-score group) and those who scored 5–6 group (the high-score group). Overall, 236 cardiovascular events were observed during the follow-up period (median, 1,159 days). Results: Kaplan-Meier analysis showed that there were significant differences in composite cardiovascular events and HF-related events between the intermediate-score group and the high-score group (p = 0.003 and p < 0.001, respectively). Multivariate Cox proportional hazards analysis showed that the HFA-PEFF scores significantly predicted future HF-related events (hazard ratio, 1.66; 95% confidence interval [CI], 1.11 to 2.50; p = 0.014); receiver operating characteristic analysis confirmed this relationship (area under the curve, 0.633; 95% CI, 0.574 to 0.692; p < 0.001). The cutoff HFA-PEFF score for the identification of HF-related events was 4.5. Decision curve analysis revealed that combining the HFA-PEFF score with conventional prognostic factors improved the prediction of HF-related events. Conclusions: HFA-PEFF scores may be useful for predicting HF-related events in HFpEF patients.
참고문헌 (43)
- Owan TE, "Trends in prevalence and outcome of heart failure with preserved ejection fraction", N Engl J Med, 355, pp.251~259 (2006)
- Vasan RS, "Defining diastolic heart failure : a call for standardized diagnostic criteria", Circulation, 101, pp.2118~2121 (2000)
- Tokitsu T, "Clinical significance of pulse pressure in patients with heart failure with preserved left ventricular ejection fraction", Eur J Heart Fail, 18, pp.1353~1361 (2016)
- Fujisue K, "Prognostic significance of polyvascular disease in heart failure with preserved left ventricular ejection fraction", Medicine(Baltimore), 98, pp.e15959~ (2019)
- Nishihara T, "Serum potassium and cardiovascular events in heart failure with preserved left ventricular ejection fraction patients", Am J Hypertens, 31, pp.1098~1105 (2018)
- Nishihara T, "Clinical significance of serum magnesium levels in patients with heart failure with preserved ejection fraction", Medicine(Baltimore), 98, pp.e17069~ (2019)
- Sueta D, "H2FPEF score as a prognostic value in HFpEF patients", Am J Hypertens, 32, pp.1082~1090 (2019)
- Komorita T, "The controlling nutritional status score predicts outcomes of cardiovascular events in patients with heart failure with preserved ejection fraction", Int J Cardiol Heart Vasc, 29, pp.100563~ (2020)
- Oike F, "Clinical significance of diastolic late mitral annular velocity in heart failure with preserved ejection fraction", Int J Cardiol, 316, pp.145~151 (2020)
- Kaku H, "Impact of hospital practice factors on mortality in patients hospitalized for heart failure in Japan : an analysis of a large number of health records from a nationwide claims-based database, the JROAD-DPC", Circ J, 84, pp.742~753 (2020)
- Pieske B, "How to diagnose heart failure with preserved ejection fraction : the HFA-PEFF diagnostic algorithm : a consensus recommendation from the Heart Failure Association(HFA)of the European Society of Cardiology(ESC)", Eur Heart J, 40, pp.3297~3317 (2019)
- Barandiaran Aizpurua A, "Validation of the HFA-PEFF score for the diagnosis of heart failure with preserved ejection fraction", Eur J Heart Fail, 22, pp.413~421 (2020)
- Mi-Na Kim, "Heart failure with preserved ejection fraction: insights from recent clinical researches", The Korean Journal of Internal Medicine, 35(3), pp.514~534 (2020), 대한내과학회[DOI]
- Sotomi Y, "Prognostic significance of the HFA-PEFF score in patients with heart failure with preserved ejection fraction", ESC Heart Fail, 8, pp.2154~2164 (2021)
- New York Heart Association Criteria Committee, "Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels" (1979), Little Brown
- Tabata N, "Outcome of current and history of cancer on the risk of cardiovascular events following percutaneous coronary intervention : a Kumamoto University Malignancy and Atherosclerosis(KUMA)study", Eur Heart J Qual Care Clin Outcomes, 4, pp.290~300 (2018)
- Sueta D, "Differential predictive factors for cardiovascular events in patients with or without cancer history", Medicine(Baltimore), 98, pp.e17602~ (2019)
- Tabata N, "A retrospective study of arterial stiffness and subsequent clinical outcomes in cancer patients undergoing percutaneous coronary intervention", J Hypertens, 37, pp.754~764 (2019)
- Matsuo S, "Revised equations for estimated GFR from serum creatinine in Japan", Am J Kidney Dis, 53, pp.982~992 (2009)
- Thygesen K, "Fourth universal definition of myocardial infarction(2018)", Circulation, 138, pp.e618~e651 (2018)
- Anand IS, "Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction : findings from the I-PRESERVE trial", Circ Heart Fail, 4, pp.569~577 (2011)
- Kristensen SL, "Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction : a report from the I-Preserve Trial(irbesartan in heart failure with preserved ejection fraction)", Circulation, 135, pp.724~735 (2017)
- Leening MJ, "Net reclassification improvement : computation, interpretation, and controversies : a literature review and clinician’s guide", Ann Intern Med, 160, pp.122~131 (2014)
- Thomas LE, "Application of net reclassification index to non-nested and point-based risk prediction models : a review", Eur Heart J, 40, pp.1880~1887 (2019)
- Zhang Z, "Decision curve analysis : a technical note", Ann Transl Med, 6, pp.308~ (2018)
- Shiba N, "Analysis of chronic heart failure registry in the Tohoku district : third year follow-up", Circ J, 68, pp.427~434 (2004)
- Shiba N, "Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan : first report from the CHART-2 study", Circ J, 75, pp.823~833 (2011)
- Tsuchihashi-Makaya M, "Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology(JCARE-CARD)", Circ J, 73, pp.1893~1900 (2009)
- Meta-analysis Global Group in Chronic Heart Failure(MAGGIC), "The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction : an individual patient data meta-analysis", Eur Heart J, 33, pp.1750~1757 (2012)
- Tsuji K, "Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study", Eur J Heart Fail, 19, pp.1258~1269 (2017)
- Paulus WJ, "A novel paradigm for heart failure with preserved ejection fraction : comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation", J Am Coll Cardiol, 62, pp.263~271 (2013)
- Daimon M, "Gender differences in age-related changes in left and right ventricular geometries and functions. Echocardiography of a healthy subject group", Circ J, 75, pp.2840~2846 (2011)
- Yusuf S, "Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction : the CHARM-Preserved Trial", Lancet, 362, pp.777~781 (2003)
- Pitt B, "Spironolactone for heart failure with preserved ejection fraction", N Engl J Med, 370, pp.1383~1392 (2014)
- Faris RF, "Diuretics for heart failure", Cochrane Database Syst Rev, 2, pp.CD003838~ (2012)
- Khush KK, "Effect of high-dose atorvastatin on hospitalizations for heart failure : subgroup analysis of the Treating to New Targets(TNT)study", Circulation, 115, pp.576~583 (2007)
- Kjekshus J, "Rosuvastatin in older patients with systolic heart failure", N Engl J Med, 357, pp.2248~2261 (2007)
- Reddy Y, "A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction", Circulation, 138, pp.861~870 (2018)
- Sepehrvand N, "External validation of the H2F-PEF model in diagnosing patients with heart failure and preserved ejection fraction", Circulation, 139, pp.2377~2379 (2019)
- Suzuki S, "H2FPEF score for predicting future heart failure in stable outpatients with cardiovascular risk factors", ESC Heart Fail, 7, pp.65~74 (2020)
- Tao Y, "H2FPEF score predicts 1-year rehospitalisation of patients with heart failure with preserved ejection fraction", Postgrad Med J, 97, pp.164~167 (2021)
- Selvaraj S, "Application of diagnostic algorithms for heart failure with preserved ejection fraction to the community", JACC Heart Fail, 8, pp.640~653 (2020)
- Nagueh SF, "Recommendations for the evaluation of left ventricular diastolic function by echocardiography : an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging", J Am Soc Echocardiogr, 29, pp.277~314 (2016)